Experimental Abemaciclib Improves Outcomes in Advanced, HR+ BC

Options
Moderators
Moderators Member Posts: 25,912

Experimental Abemaciclib Improves Outcomes in Advanced-Stage, Hormone-Receptor-Positive Disease
September 14, 2017
Results from a third study show that the experimental targeted therapy medicine abemaciclib improved progression-free survival in postmenopausal women diagnosed with hormone-receptor-positive, HER2-negative, advanced-stage breast cancer. Read more...

Categories